ArticleJournal of proteome research2025
Comparative Proteomic Characterization of Serum-Free Cultivated HepG2 Cells Reveals Upregulated Drug Metabolism and Increased Oxidative Stress Protection.
Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cell line identity rather than medium composition determines transcriptomic profiles of HepaRG and HuH7 cells cultured in chemically defined or serum-based media: comparison with primary human hepatocytes.Archives of toxicology · 2026Article
- Phenotypic and functional characterization of THP-1-derived macrophages: impact of serum and serum-free differentiation conditions on surface marker expression and immune function.Frontiers in toxicology · 2026Article
- Effects of low-serum adaptation on growth and protein expression in stably lactoferrin-overexpressing mammary alveolar cells.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fetal bovine serum (FBS) is commonly used in cell culture models despite being considered critical from both an ethical and scientific standpoint. Since it has been used for many years with a variety of different cells and cell types, research has become dependent on its use, and scientists hesitate to change their working model without solid data demonstrating the usability of serum-free cultivated cells in their desired applications. To shed light on the highly complex issue of dietary demands of cells in culture and the impact of media supplements on cellular behavior, we performed a comparative proteomic characterization between HepG2 cells cultivated in serum-free or FBS-containing conditions with a focus set on drug metabolism and oxidative stress response, the main application field of the HepG2 cell line. We observed the predicted upregulation of multiple pathways associated with drug metabolism and oxidative stress protection, as well as a strong overexpression of multiple antioxidative enzymes such as glutathione peroxidase and glutathione S-transferase at the protein expression level. We confirmed that increased enzyme expression correlates with higher enzyme activity in vitro and linked increased glutathione peroxidase activity to selenium supranutrition under serum-free conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.